Cargando…
Transient hypoalgesia after COVID-19 infection
INTRODUCTION: Loss of smell or taste are often-cited complications during COVID-19 disease, but there is no clear evidence for affection of the peripheral nervous system. METHODS: Here, we report a 48-year-old man presenting with persistent dysgeusia and hypoalgesia of the lower legs, hands, and che...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920299/ https://www.ncbi.nlm.nih.gov/pubmed/35295965 http://dx.doi.org/10.1097/PR9.0000000000000990 |
_version_ | 1784669098597154816 |
---|---|
author | Becker, Juliane Papagianni, Aikaterini Herrmann, Eva Nöller, Frank Sommer, Claudia Rittner, Heike L. |
author_facet | Becker, Juliane Papagianni, Aikaterini Herrmann, Eva Nöller, Frank Sommer, Claudia Rittner, Heike L. |
author_sort | Becker, Juliane |
collection | PubMed |
description | INTRODUCTION: Loss of smell or taste are often-cited complications during COVID-19 disease, but there is no clear evidence for affection of the peripheral nervous system. METHODS: Here, we report a 48-year-old man presenting with persistent dysgeusia and hypoalgesia of the lower legs, hands, and cheeks after COVID-19 infection in Spring 2020. RESULTS: Upon clinical examination 7 months after the infection, the patient could not feel pain after pinprick stimuli. Quantitative sensory testing revealed increased thermal detection thresholds at the face but no changes at the foot. Electrical C-fiber stimulation elicited lower pain ratings at the distal leg compared with the proximal leg, but overall higher pain ratings than in healthy control subjects. The axon flare reaction in response to histamine and acetylcholine was almost absent with no pain sensation. Skin punch biopsy revealed a reduced intraepidermal nerve fiber density at the lower leg, and transient receptor potential vanilloid 1 and calcitonin gene-related peptide immunoreactivity were similar to a healthy control. Symptoms and positive tests improved 5 months later. CONCLUSION: In summary, we describe a case of hypoalgesia after COVID-19 disease. Studies investigating long-COVID syndrome should test not only for painful neuropathic symptoms but also for hypoalgesia, especially in patients with prolonged dysgeusia. |
format | Online Article Text |
id | pubmed-8920299 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer |
record_format | MEDLINE/PubMed |
spelling | pubmed-89202992022-03-15 Transient hypoalgesia after COVID-19 infection Becker, Juliane Papagianni, Aikaterini Herrmann, Eva Nöller, Frank Sommer, Claudia Rittner, Heike L. Pain Rep COVID-19 and pain INTRODUCTION: Loss of smell or taste are often-cited complications during COVID-19 disease, but there is no clear evidence for affection of the peripheral nervous system. METHODS: Here, we report a 48-year-old man presenting with persistent dysgeusia and hypoalgesia of the lower legs, hands, and cheeks after COVID-19 infection in Spring 2020. RESULTS: Upon clinical examination 7 months after the infection, the patient could not feel pain after pinprick stimuli. Quantitative sensory testing revealed increased thermal detection thresholds at the face but no changes at the foot. Electrical C-fiber stimulation elicited lower pain ratings at the distal leg compared with the proximal leg, but overall higher pain ratings than in healthy control subjects. The axon flare reaction in response to histamine and acetylcholine was almost absent with no pain sensation. Skin punch biopsy revealed a reduced intraepidermal nerve fiber density at the lower leg, and transient receptor potential vanilloid 1 and calcitonin gene-related peptide immunoreactivity were similar to a healthy control. Symptoms and positive tests improved 5 months later. CONCLUSION: In summary, we describe a case of hypoalgesia after COVID-19 disease. Studies investigating long-COVID syndrome should test not only for painful neuropathic symptoms but also for hypoalgesia, especially in patients with prolonged dysgeusia. Wolters Kluwer 2022-03-11 /pmc/articles/PMC8920299/ /pubmed/35295965 http://dx.doi.org/10.1097/PR9.0000000000000990 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The International Association for the Study of Pain. https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License 4.0 (CC BY-NC-SA) (https://creativecommons.org/licenses/by-nc-sa/4.0/) which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | COVID-19 and pain Becker, Juliane Papagianni, Aikaterini Herrmann, Eva Nöller, Frank Sommer, Claudia Rittner, Heike L. Transient hypoalgesia after COVID-19 infection |
title | Transient hypoalgesia after COVID-19 infection |
title_full | Transient hypoalgesia after COVID-19 infection |
title_fullStr | Transient hypoalgesia after COVID-19 infection |
title_full_unstemmed | Transient hypoalgesia after COVID-19 infection |
title_short | Transient hypoalgesia after COVID-19 infection |
title_sort | transient hypoalgesia after covid-19 infection |
topic | COVID-19 and pain |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920299/ https://www.ncbi.nlm.nih.gov/pubmed/35295965 http://dx.doi.org/10.1097/PR9.0000000000000990 |
work_keys_str_mv | AT beckerjuliane transienthypoalgesiaaftercovid19infection AT papagianniaikaterini transienthypoalgesiaaftercovid19infection AT herrmanneva transienthypoalgesiaaftercovid19infection AT nollerfrank transienthypoalgesiaaftercovid19infection AT sommerclaudia transienthypoalgesiaaftercovid19infection AT rittnerheikel transienthypoalgesiaaftercovid19infection |